Antiarrhythmic treatment: an overview.

Area of Science:

• Cardiology
• Electrophysiology

Background:

• Atrial and ventricular arrhythmias contribute to significant patient morbidity and mortality.
• Abnormalities in impulse generation or conduction are primary mechanisms driving these arrhythmias.
• Ventricular arrhythmias are particularly critical due to their association with sudden cardiac death, a leading public health concern.

Purpose of the Study:

• To review the mechanisms, detection, classification, and management of atrial and ventricular arrhythmias.
• To highlight the importance of identifying and treating malignant ventricular arrhythmias.

Main Methods:

• Electrocardiographic recording and provocative testing (e.g., exercise, programmed ventricular stimulation) are used for detection and classification.
• Development of drugs with diverse mechanisms of action to treat arrhythmias.
• Classification of ventricular arrhythmias into benign, potentially malignant, and malignant categories.

Main Results:

• Benign arrhythmias require no treatment.
• Potentially malignant arrhythmias may benefit from prophylactic drug therapy.
• Malignant arrhythmias necessitate aggressive treatment including drugs, surgery, or electronic devices.

Conclusions:

• Effective management of malignant ventricular arrhythmias involves programmatic approaches like electrophysiologic studies or Holter/exercise monitoring.
• Both approaches, though complex and costly, are effective in guiding treatment selection for malignant ventricular arrhythmias.